Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

This publication has 37 references indexed in Scilit:

• Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
  Systematic Reviews, 2013
• Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials
  American Heart Journal, 2011
• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
  New England Journal of Medicine, 2011
• Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease
  Circulation: Heart Failure, 2011
• Efficacy and Safety of Nebivolol in Elderly Heart Failure Patients with Impaired Renal Function: Insights from the SENIORS Trial
  European Journal of Heart Failure, 2009
• Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy
  JACC, 2003
• Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
  Statistics in Medicine, 2002
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Proteinuria in Congestive Heart Failure
  American Journal of Nephrology, 1983